A series of preclinical experiments using patient-derived tumor xenografts (PDXs) and mouse models point to potential treatments for patients with a rapidly-progressing and resistant subgroup of tumor cells.
Interesting and Fun Facts
936 ViewsHundreds of interesting facts about your body that you never knew. Updated weekly with new facts
Read more ...
Leave a Reply
Your email address will not be published. Required fields are marked (required)